Pan, Min
Liu, Weidong
Zhang, Zhixin
Li, Tong
Xie, Weibin
Article History
Received: 29 June 2023
Accepted: 28 May 2024
First Online: 4 June 2024
Declarations
:
: This study was approved by the Ethics Committee of The Third People’s Hospital of Changzhou (Approval No. 02A-A20230004) and was registered with the Chinese Clinical Trial Registry (ChiCTR2300071508) in 17/05/2023.The informed consent was obtained from all patients participating. The study protocol was performed in accordance with relevant guidelines and regulations. Our methodology followed the international guidelines for observational studies.
: Not applicable.
: The authors declare no competing interests.